GAO Ling,YUAN Jing,QIN Wenjie,et al.Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation[J].ZHONGGUO YAOFANG,2024,35(24):3071-3075.
GAO Ling,YUAN Jing,QIN Wenjie,et al.Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation[J].ZHONGGUO YAOFANG,2024,35(24):3071-3075. DOI: 10.6039/j.issn.1001-0408.2024.24.18.
Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation
To provide a reference for pharmaceutical care in patients with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation.
METHODS
2
Clinical pharmacists participated in the treatment practice of a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation. Because the patient had a hemorrhagic transformation after cerebral infarction after stent implantation and arterial thrombolysis, the clinical pharmacists recommended stopping antiplatelet drugs and giving plasma and cold precipitation; because D-dimer was significantly elevated, the clinical pharmacists recommended anticoagulant therapy with low-molecular heparin. Due to the patient’s recurrence of hemorrhagic transformation after cerebral infarction, the clinical pharmacists recommended discontinuing rivaroxaban and administering human prothrombin complex concentrate.
RESULTS
2
The physician adopted the clinical pharmacists’ recommendation. After treatment, the patient’s condition tended to improve steadily and was allowed to be discharged with medication.
CONCLUSIONS
2
The clinical pharmacists assessed the individualized risk and optimized the patient’s medication regimen by suggesting discontinuation of antiplatelet and anticoagulant drugs, carrying out pharmaceutical care such as coagulation index monitoring, determining the time and indications for restarting anticoagulation, and pharmaceutical monitoring, to ensure the safety and efficacy of the patient’s medication.
Branch of Neurology of Chinese Medical Association , Cerebrovascular Disease Group of Branch of Neurology of Chinese Medical Association . Consensus on diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke in China 2019 [J ] . Chin J Neurol , 2019 , 52 ( 4 ): 252 - 265 .
Branch of Neurosurgery of Chinese Medical Association , Branch of Emergency Physicians of Chinese Medical Doctor Association , Stroke Screening and Prevention Project Committee of the National Health Commission . Guidelines for multidisciplinary diagnosis and treatment of cerebral hemorrhage associated with bleeding and coagulation dysfunction in China [J ] . Chin J Crit Care Med , 2021 , 41 ( 8 ): 647 - 660 .
GREENBERG S M , ZIAI W C , CORDONNIER C , et al . 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage:a guideline from the American Heart Association/American Stroke Association [J ] . Stroke , 2022 , 53 ( 7 ): e282 - e361 .
MAN S M , SOLOMON N , MAC GRORY B , et al . Trends in stroke thrombolysis care metrics and outcomes by race and ethnicity,2003-2021 [J ] . JAMA Netw Open , 2024 , 7 ( 2 ): e2352927 .
CHEN C H , SHOAMANESH A , COLORADO P , et al . Hemorrhagic transformation in noncardioembolic acute ischemic stroke:MRI analysis from pacific-stroke [J ] . Stroke , 2024 , 55 ( 6 ): 1477 - 1488 .
KOVÁCS K B , BENCS V , HUDÁK L , et al . Hemorrhagic transformation of ischemic strokes [J ] . Int J Mol Sci , 2023 , 24 ( 18 ): 14067 .
Chinese Stroke Association , Chinese Interventional Neuroradiology Society , Intervention Group of Committee of Stroke Prevention and Control of Chinese Preventive Medicine Association . Chinese experts consensus on clinical application of tirofiban in atherosclerotic cerebrovascular diseases [J ] . Chin J Stroke , 2019 , 14 ( 10 ): 1034 - 1044 .
PAN X , LI J H , XU L , et al . Safety of prophylactic heparin in the prevention of venous thromboembolism after spontaneous intracerebral hemorrhage:a meta-analysis [J ] . J Neurol Surg A Cent Eur Neurosurg , 2020 , 81 ( 3 ): 253 - 260 .
STEFFEL J , VERHAMME P , POTPARA T S , et al . The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation:executive summary [J ] . Europace , 2018 , 20 ( 8 ): 1231 - 1242 .
Branch of Neurology of Chinese Medical Association , Cerebrovascular Disease Group of Branch of Neurology of Chinese Medical Association . Guidelines for diagnosis and treatment of cerebral hemorrhage in China:2014 [J ] . Chin J Neurol , 2015 , 48 ( 6 ): 435 - 444 .
PENNLERT J , ASPLUND K , ERIKSSON M . Response by Pennlert et al to letter regarding article,“optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation” [J ] . Stroke , 2017 , 48 ( 4 ): e116 .
LIU X H , SONG J C , ZHANG J H , et al . Chinese experts consensus for standardized diagnosis and treatment of antithrombotic drug-related bleeding [J ] . Med J Chin People’s Liberation Army , 2022 , 47 ( 12 ): 1169 - 1179 .
SMITH M M , SCHROEDER D R , NELSON J A , et al . Prothrombin complex concentrate vs plasma for post-cardiopulmonary bypass coagulopathy and bleeding:a randomized clinical trial [J ] . JAMA Surg , 2022 , 157 ( 9 ): 757 - 764 .
NAGREBETSKY A , AL-SAMKARI H , DAVIS N M , et al . Perioperative thrombocytopenia:evidence,evaluation,and emerging therapies [J ] . Br J Anaesth , 2019 , 122 ( 1 ): 19 - 31 .
Neurological Injuries Specialty Group of Branch of Traumatology of Chinese Medical Association , Craniocerebral Trauma Specialty Group of Branch of Neurosurgery of Chinese Medical Association . China expert consensus on prevention and treatment of stress ulcer after traumatic brain injury [J ] . Chin J Neurosurg , 2018 , 34 ( 7 ): 649 - 652 .
One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine
Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined with thyroid cancer
Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia
Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model
Pharmaceutical care for a patient with rhino-orbito-cerebral mucormycosis
Related Author
XU Lina
FANG Yingli
WANG Xiangling
DU Pengcheng
ZHANG Guangquan
LU Qi
YAN Dan
XU Silu
Related Institution
Dept. of Oncology, Qilu Hospital of Shandong University
Dept. of Clinical Pharmacy, Dezhou Hospital, Qilu Hospital of Shandong University
Dept. of Clinical Pharmacy, Qilu Hospital of Shandong University
Dept. of Pharmacy, Xuzhou Cancer Hospital
Dept. of Pharmacy, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/the Affiliated Cancer Hospital of Nanjing Medical University